ARCHIVES

IOM Committee Focuses on Studies Needed To Protect Patients On Omics-Based Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 41 | November 4, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Would Add Money For Centers If Number Go Up, Greenwald Says; Five Options For Changes Listed

April 27, 1984

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992

House, Senate Meet On Appropriations Bill Differences

October 6, 1989

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

May 25, 1979

NTP Board Approves Concept Of Human Cell Assay For Genetic Toxicity

March 25, 1983